Invention Grant
- Patent Title: Multivalent saccharide complex, radioactive multivalent saccharide complex contrast agent, and use thereof
-
Application No.: US15887045Application Date: 2018-02-02
-
Publication No.: US10434196B2Publication Date: 2019-10-08
- Inventor: Hung-Man Yu , Wuu-Jyh Lin , Mei-Hui Wang , Chun-Hao Tseng
- Applicant: Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C
- Applicant Address: TW Taoyuan
- Assignee: INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN, R.O.C
- Current Assignee: INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN, R.O.C
- Current Assignee Address: TW Taoyuan
- Agency: Locke Lord LLP
- Agent Tim Tingkang Xia, Esq.
- Priority: TW106132629A 20170922
- Main IPC: A61K51/04
- IPC: A61K51/04 ; C07H23/00
Abstract:
Disclosed herein are a multivalent saccharide complex, a radioactive multivalent saccharide complex contrast agent and use thereof. The multivalent saccharide complex has a chelator, a linker, and glucose, and is configured to diagnose and evaluate the therapeutic effect of cancers.
Public/Granted literature
Information query
